NDC 0169-2035-90
SOGROYA 3.3 mg/mL
somapacitan-beco · INJECTION, SOLUTION
Sogroya is a prescription injection used to treat growth hormone deficiency in adults. It is administered under the skin and belongs to a class of medications that replace or supplement growth hormone in the body.
Key Facts
- Brand Name
- SOGROYA
- Generic Name
- somapacitan-beco
- NDC Code (Package)
0169-2035-90- NDC Code (Product)
0169-2035- Manufacturer
- Novo Nordisk
- Strength
- 3.3 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761156
- Marketing Start
- 05/01/2023
Recall History
No Recall HistoryView Full Drug Page
SOGROYA — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.